Work

P3.18.13 Atezolizumab +/- Tiragolumab Before and After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer (AFT-57)

Year: 2025

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2025.09.1029

Authors: H.J. Ross, D.E. Kozono, M.D. Mix, J.J. Urbanic, T.M. Williams, T. O'Donnell, I. Bara, K. Schulze, X. Wang, G. Nelson, T. Stinchcombe

Institutions: Rush University, Dana-Farber Cancer Institute, SUNY Upstate Medical University, University of California San Diego, City Of Hope National Medical Center, City of Hope, Alliance Foundation Trials, Genentech, Duke University, Mayo Clinic

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4415520469

FWCI:

Cites:

Cited by:

Related to: 10